Rheumatoid Arthritis
In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include the SELECT-CHOICE study, the EXCEED trial, Avacopan in AAV, BeST mortality outcomes, BLISS-LN study, biosimilars and tofa in systemic sclerosis.
Autoinflammatory/Still's Disease Panel - EULAR2020
Drs. Olga Petryna, Petros Efthimiou, Apostolos Kontzias and Jack Cush discuss autoinflammatory highlights from the Virtual EULAR 2020 meeting June 3-6
These were my top abstracts from Thursday, 4th of June at EULAR 2020:
These were my top abstracts from Thursday, 4th of June at EULAR 2020:
Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial spondyloarthropathies and psoriatic arthritis. Actually, this question has been brewing for several years now, but only now we get more data to form more or less feasible answer. So let’s see what EULAR 2020 has to offer.
Here is my top-five from day one at EULAR:
Updated EULAR Recommendations for RA Management
Dr. Kathryn Dao from EULAR2020 Virtual Conference
MSK Flares with Vedolizumab
Dr. Rachel Tate from EULAR2020 on Abstract FRI0294
Easier Early Arthritis
Dr. David Liew from EULAR2020 Virtual Conference
Early Patient Referrals
Preclinical RA patients
Olga Petryna DrPetryna
5 years ago
#EULAR2020 #op0202-hpr 🇬🇧 study remind that resistant training benefits patients with inflammatory arthritides: improved function, wellbeing, self-efficacy, strength and fatigue.improved balance&endurance helps prevent falls @RheumNow https://t.co/MH7VD6zH9t
David Liew drdavidliew
5 years ago
Do patients with early RA need to see a rheumatologist in the first 6w after Sx onset, or will 12w do?
Getting in before 6w is better for drug-free remission than 12w, but not for radiographic progression - although >12w is too long!
Leiden/ESPOIR OP0222 #EULAR2020 @RheumNow https://t.co/uaLsK4TMSR
David Liew drdavidliew
5 years ago
For your new diagnosis RA patients, how long have they typically had symptoms for by the time they first see you?
#EULAR2020 @RheumNow
David Liew drdavidliew
5 years ago
Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis?
@Yuz6Yusof found rituximab had better 'lung survival' vs TNFi (similar baseline stats)
Something to consider in these difficult-to-treat pts?
@LeedsBRC Newcastle THU0143 #EULAR2020 @RheumNow https://t.co/XpffkDNqhU
Poster Hall